|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-1.91/-1.85
|
企业价值
94.68M
|
资产负债 |
每股账面净值
4.80
|
现金流量 |
现金流量率
--
|
损益表 |
收益
802.00K
|
每股收益
0.34
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/04 20:22 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer. |